Loading...

Immunotherapy advances for glioblastoma

Survival for patients with glioblastoma, the most common high-grade primary CNS tumor, remains poor despite multiple therapeutic interventions including intensifying cytotoxic therapy, targeting dysregulated cell signaling pathways, and blocking angiogenesis. Exciting, durable clinical benefits have...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Reardon, David A., Freeman, Gordon, Wu, Catherine, Chiocca, E. Antonio, Wucherpfennig, Kai W., Wen, Patrick Y., Fritsch, Edward F., Curry, William T., Sampson, John H., Dranoff, Glenn
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201077/
https://ncbi.nlm.nih.gov/pubmed/25190673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou212
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!